Menu
1 min read · estimated
APPROVED USE
What FDA approved
Patients with locally advanced or metastatic urothelial carcinoma who are ineligible for any platinum-containing chemotherapy.
LAMPGEN ANALYSIS
Why it matters
The traditional action narrowed the earlier indication to patients who cannot receive any platinum regimen.
What research teams should watch
Record platinum eligibility by agent rather than equating cisplatin ineligibility with ineligibility for all platinum chemotherapy.
PRIMARY RECORDS